Exact Mass: 755.6063566

Exact Mass Matches: 755.6063566

Found 500 metabolites which its exact mass value is equals to given mass value 755.6063566, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

GlcCer(d18:1/20:0)

N-[(2S,3R,4E)-3-hydroxy-1-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-4-en-2-yl]icosanamide

C44H85NO8 (755.627485)


GlcCer(d18:1/20:0) is a glycosphingolipid (ceramide and oligosaccharide)or oligoglycosylceramide with one or more sialic acids (i.e. n-acetylneuraminic acid) linked on the sugar chain. It is a component the cell plasma membrane which modulates cell signal transduction events. Gangliosides have been found to be highly important in immunology. Ganglioside GL1a carries a net-negative charge at pH 7.0 and is acidic. Gangliosides can amount to 6\\% of the weight of lipids from brain, but they are found at low levels in all animal tissues.Cerebrosides are glycosphingolipids. There are four types of glycosphingolipids, the cerebrosides, sulfatides, globosides and gangliosides. Cerebrosides have a single sugar group linked to ceramide. The most common are galactocerebrosides (containing galactose), the least common are glucocerebrosides (containing glucose). Galactocerebrosides are found predominantly in neuronal cell membranes. In contrast glucocerebrosides are not normally found in membranes. Instead, they are typically intermediates in the synthesis or degradation of more complex glycosphingolipids. Galactocerebrosides are synthesized from ceramide and UDP-galactose. Excess lysosomal accumulation of glucocerebrosides is found in Gaucher disease. A glycosphingolipid (ceramide and oligosaccharide)or oligoglycosylceramide with one or more sialic acids (i.e. n-acetylneuraminic acid) linked on the sugar chain. It is a component the cell plasma membrane which modulates cell signal transduction events. Gangliosides have been found to be highly important in immunology. Ganglioside GL1a carries a net-negative charge at pH 7.0 and is acidic. Gangliosides can amount to 6\\% of the weight of lipids from brain, but they are found at low levels in all animal tissues.

   

PE(20:1(11Z)/P-18:1(11Z))

(2-aminoethoxy)[(2R)-3-[(11Z)-icos-11-enoyloxy]-2-[(1Z,11Z)-octadeca-1,11-dien-1-yloxy]propoxy]phosphinic acid

C43H82NO7P (755.5828592)


PE(20:1(11Z)/P-18:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:1(11Z)/P-18:1(11Z)), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of plasmalogen 18:1n7 at the C-2 position. The eicosenoic acid moiety is derived from vegetable oils and cod oils, while the plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

   

PE(20:1(11Z)/P-18:1(9Z))

(2-aminoethoxy)[(2R)-3-[(11Z)-icos-11-enoyloxy]-2-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]propoxy]phosphinic acid

C43H82NO7P (755.5828592)


PE(20:1(11Z)/P-18:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:1(11Z)/P-18:1(9Z)), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of plasmalogen 18:1n9 at the C-2 position. The eicosenoic acid moiety is derived from vegetable oils and cod oils, while the plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PE(20:1(11Z)/P-18:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:1(11Z)/P-18:1(9Z)), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of plasmalogen 18:1n9 at the C-2 position. The eicosenoic acid moiety is derived from vegetable oils and cod oils, while the plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(20:2(11Z,14Z)/P-18:0)

(2-aminoethoxy)[(2R)-3-[(11Z,14Z)-icosa-11,14-dienoyloxy]-2-[(1Z)-octadec-1-en-1-yloxy]propoxy]phosphinic acid

C43H82NO7P (755.5828592)


PE(20:2(11Z,14Z)/P-18:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:2(11Z,14Z)/P-18:0), in particular, consists of one chain of eicosadienoic acid at the C-1 position and one chain of plasmalogen 18:0 at the C-2 position. The eicosadienoic acid moiety is derived from fish oils and liver, while the plasmalogen 18:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

   

PE(22:2(13Z,16Z)/P-16:0)

(2-aminoethoxy)[(2R)-3-[(13Z,16Z)-docosa-13,16-dienoyloxy]-2-[(1Z)-hexadec-1-en-1-yloxy]propoxy]phosphinic acid

C43H82NO7P (755.5828592)


PE(22:2(13Z,16Z)/P-16:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(22:2(13Z,16Z)/P-16:0), in particular, consists of one chain of docosadienoic acid at the C-1 position and one chain of plasmalogen 16:0 at the C-2 position. The docosadienoic acid moiety is derived from animal fats, while the plasmalogen 16:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

   

Galactosylceramide (d18:1/20:0)

N-[(4Z)-3-Hydroxy-1-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-4-en-2-yl]icosanimidate

C44H85NO8 (755.627485)


Galactosylceramides (GalCer) are non-acidic monoglycosphingolipids, i.e. a sphingolipid with one carbohydrate moiety attached to a ceramide unit. They are an intermediate in sphingolipid metabolism and is the second to last step in the synthesis of digalactosylceramidesulfate. GalCer is generated from ceramide via the enzyme UDP-galactose ceramide galactosyltransferase [EC:2.4.1.47]. It can be converted to digalactosylceramide via the enzyme glycosyltransferases [EC 2.4.1.-]. Galactosylceramide is the principal glycosphingolipid in brain tissue, hence the trivial name "cerebroside", which was first conferred on it in 1874. Galactosylceramides are found in all nervous tissues, but they can amount to 2\\% of the dry weight of grey matter and 12\\% of white matter. They are major constituents of oligodendrocytes. Synthesis of galactosylceramide takes place on the lumenal surface of the endoplasmic reticulum, although it has free access to the cytosolic surface by an energy-independent flip-flop process. GalCer sits in the extracellular leaflet of cell membranes in nanometer sized domains or rafts. The local clustering of GalCer within rafts is thought to facilitate the initial adhesion of certain viruses, including HIV-1 and bacteria to cells through multivalent interactions between receptor proteins and GalCer. A defect in the degradation of cerbrosides leads to a disorder called Krabbe disease. Krabbe disease (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare, often fatal degenerative disorder that affects the myelin sheath of the nervous system. Krabbe disease is caused by mutations in the GALC gene, which causes a deficiency of galactosylceramidase. Infants with Krabbe disease are normal at birth. Symptoms begin between the ages of 3 and 6 months with irritability, fevers, limb stiffness, seizures, feeding difficulties, vomiting, and slowing of mental and motor development. There are also juvenile- and adult-onset cases of Krabbe disease, which have similar symptoms but slower progression. In infants, the disease is generally fatal before age 2. Patients with late-onset Krabbe disease tend to have a slower progression of the disease and live significantly longer.Cerebrosides are glycosphingolipids. There are four types of glycosphingolipids, the cerebrosides, sulfatides, globosides and gangliosides. Cerebrosides have a single sugar group linked to ceramide. The most common are galactocerebrosides (containing galactose), the least common are glucocerebrosides (containing glucose). Galactocerebrosides are found predominantly in neuronal cell membranes. In contrast glucocerebrosides are not normally found in membranes. Instead, they are typically intermediates in the synthesis or degradation of more complex glycosphingolipids. Galactocerebrosides are synthesized from ceramide and UDP-galactose. Excess lysosomal accumulation of glucocerebrosides is found in Gaucher disease. Galactosylceramide (GalCer) is a non-acidic monoglycosphingolipid, i.e. a sphingolipid with one carbohydrate moiety attached to a ceramide unit. It is an intermediate in sphingolipid metabolism and is the second to last step in the synthesis of digalactosylceramidesulfate. GalCer is generated from ceramide via the enzyme UDP-galactose ceramide galactosyltransferase [EC:2.4.1.47]. It can be converted to digalactosylceramide via the enzyme glycosyltransferases [EC 2.4.1.-]. Galactosylceramide is the principal glycosphingolipid in brain tissue, hence the trivial name "cerebroside", which was first conferred on it in 1874. Galactosylceramides are found in all nervous tissues, but they can amount to 2\\% of the dry weight of grey matter and 12\\% of white matter. They are major constituents of oligodendrocytes. Synthesis of galactosylceramide takes place on the lumenal surface of the endoplasmic reticulum, although it has free access to the cytosolic surface by an energy-independent flip-flop process. GalCer sits in the extracellular leaflet of cell membranes in nanometer sized domains or rafts. The local clustering of GalCer within rafts is thought to facilitate the initial adhesion of certain viruses, including HIV-1 and bacteria to cells through multivalent interactions between receptor proteins and GalCer. A defect in the degradation of cerbrosides leads to a disorder called Krabbe disease. Krabbe disease (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare, often fatal degenerative disorder that affects the myelin sheath of the nervous system. Krabbe disease is caused by mutations in the GALC gene, which causes a deficiency of galactosylceramidase. Infants with Krabbe disease are normal at birth. Symptoms begin between the ages of 3 and 6 months with irritability, fevers, limb stiffness, seizures, feeding difficulties, vomiting, and slowing of mental and motor development. There are also juvenile- and adult-onset cases of Krabbe disease, which have similar symptoms but slower progression. In infants, the disease is generally fatal before age 2. Patients with late-onset Krabbe disease tend to have a slower progression of the disease and live significantly longer.

   

PC(P-18:0/P-18:1(11Z))

(2R)-3-[(1Z)-Octadec-1-en-1-yloxy]-2-[(1Z,11Z)-octadeca-1,11-dien-1-yloxy]propyl 2-(trimethylazaniumyl)ethyl phosphoric acid

C44H86NO6P (755.6192426)


PC(P-18:0/P-18:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:0/P-18:1(11Z)), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of plasmalogen 18:1n7 at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(P-18:0/P-18:1(9Z))

(2R)-3-[(1Z)-Octadec-1-en-1-yloxy]-2-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]propyl 2-(trimethylazaniumyl)ethyl phosphoric acid

C44H86NO6P (755.6192426)


PC(P-18:0/P-18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:0/P-18:1(9Z)), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of plasmalogen 18:1n9 at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(P-18:1(11Z)/P-18:0)

(2R)-2-[(1Z)-Octadec-1-en-1-yloxy]-3-[(1Z,11Z)-octadeca-1,11-dien-1-yloxy]propyl 2-(trimethylazaniumyl)ethyl phosphoric acid

C44H86NO6P (755.6192426)


PC(P-18:1(11Z)/P-18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(11Z)/P-18:0), in particular, consists of one chain of plasmalogen 18:1n7 at the C-1 position and one chain of plasmalogen 18:0 at the C-2 position. The plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney, while the plasmalogen 18:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(P-18:1(9Z)/P-18:0)

(2R)-2-[(1Z)-Octadec-1-en-1-yloxy]-3-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]propyl 2-(trimethylazaniumyl)ethyl phosphoric acid

C44H86NO6P (755.6192426)


PC(P-18:1(9Z)/P-18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(9Z)/P-18:0), in particular, consists of one chain of plasmalogen 18:1n9 at the C-1 position and one chain of plasmalogen 18:0 at the C-2 position. The plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney, while the plasmalogen 18:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(P-16:0/22:2(13Z,16Z))

(2-aminoethoxy)[(2R)-2-[(13Z,16Z)-docosa-13,16-dienoyloxy]-3-[(1Z)-hexadec-1-en-1-yloxy]propoxy]phosphinic acid

C43H82NO7P (755.5828592)


PE(P-16:0/22:2(13Z,16Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-16:0/22:2(13Z,16Z)), in particular, consists of one chain of plasmalogen 16:0 at the C-1 position and one chain of docosadienoic acid at the C-2 position. The plasmalogen 16:0 moiety is derived from animal fats, liver and kidney, while the docosadienoic acid moiety is derived from animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PE(P-16:0/22:2(13Z,16Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-16:0/22:2(13Z,16Z)), in particular, consists of one chain of plasmalogen 16:0 at the C-1 position and one chain of docosadienoic acid at the C-2 position. The plasmalogen 16:0 moiety is derived from animal fats, liver and kidney, while the docosadienoic acid moiety is derived from animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(P-18:0/20:2(11Z,14Z))

(2-aminoethoxy)[(2R)-2-[(11Z,14Z)-icosa-11,14-dienoyloxy]-3-[(1Z)-octadec-1-en-1-yloxy]propoxy]phosphinic acid

C43H82NO7P (755.5828592)


PE(P-18:0/20:2(11Z,14Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:0/20:2(11Z,14Z)), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of eicosadienoic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the eicosadienoic acid moiety is derived from fish oils and liver. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PE(P-18:0/20:2(11Z,14Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:0/20:2(11Z,14Z)), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of eicosadienoic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the eicosadienoic acid moiety is derived from fish oils and liver. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(P-18:1(11Z)/20:1(11Z))

(2-aminoethoxy)[(2R)-2-[(11Z)-icos-11-enoyloxy]-3-[(1Z,11Z)-octadeca-1,11-dien-1-yloxy]propoxy]phosphinic acid

C43H82NO7P (755.5828592)


PE(P-18:1(11Z)/20:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:1(11Z)/20:1(11Z)), in particular, consists of one chain of plasmalogen 18:1n7 at the C-1 position and one chain of eicosenoic acid at the C-2 position. The plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney, while the eicosenoic acid moiety is derived from vegetable oils and cod oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PE(P-18:1(11Z)/20:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:1(11Z)/20:1(11Z)), in particular, consists of one chain of plasmalogen 18:1n7 at the C-1 position and one chain of eicosenoic acid at the C-2 position. The plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney, while the eicosenoic acid moiety is derived from vegetable oils and cod oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(P-18:1(9Z)/20:1(11Z))

(2-aminoethoxy)[(2R)-2-[(11Z)-icos-11-enoyloxy]-3-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]propoxy]phosphinic acid

C43H82NO7P (755.5828592)


PE(P-18:1(9Z)/20:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(dm18:1(9Z)/20:1(11Z)), in particular, consists of one chain of plasmalogen 18:P-9 at the C-1 position and one chain of eicosenoic acid at the C-2 position. The plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney, while the eicosenoic acid moiety is derived from vegetable oils and cod oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PE(P-18:1(9Z)/20:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(dm18:1(9Z)/20:1(11Z)), in particular, consists of one chain of plasmalogen 18:P-9 at the C-1 position and one chain of eicosenoic acid at the C-2 position. The plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney, while the eicosenoic acid moiety is derived from vegetable oils and cod oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

Cerebroside D

N-(2-hydroxy-octadecanoyl)-1-beta-glucosyl-9-methyl-sphinga-4E,8E-dienine

C43H81NO9 (755.5911016)


   

asteriacerebroside A

asteriacerebroside A

C43H81NO9 (755.5911016)


   

Phosphatidylethanolamine alkenyl 20:1-18:2

Phosphatidylethanolamine alkenyl 20:1-18:2

C43H82NO7P (755.5828592)


   

Phosphatidylethanolamine alkenyl 18:0-20:2

Phosphatidylethanolamine alkenyl 18:0-20:2

C43H82NO7P (755.5828592)


   

Phosphatidylethanolamine alkenyl 18:1-20:1

Phosphatidylethanolamine alkenyl 18:1-20:1

C43H82NO7P (755.5828592)


   

1-O-beta-D-Galactopyranosyl-N-(2R-hydroxy-15-methylpalmitoyl)-9,17-dimethylsphinga-4E,8E-dienin

1-O-beta-D-Galactopyranosyl-N-(2R-hydroxy-15-methylpalmitoyl)-9,17-dimethylsphinga-4E,8E-dienin

C43H81NO9 (755.5911016)


   

GlcCer(d14:1/24:0)

N-(tetracosanoyl)-1-beta-glucosyl-tetradecasphing-4-enine

C44H85NO8 (755.627485)


   

GlcCer(d15:2(4E,6E)/22:0(2OH))

N-(2-hydroxy-docosanoyl)-1-beta-glucosyl-4E,6E-pentadecasphingadienine

C43H81NO9 (755.5911016)


   

C20 GlcCer

N-(eicosanoyl)-1-beta-glucosyl-sphing-4-enine

C44H85NO8 (755.627485)


   

Galbeta-Cer(d18:1/20:0)

Galbeta-Cer(d18:1/20:0)

C44H85NO8 (755.627485)


   

PE(38:2)

1-(1-Enyl-palmitoyl)-2-docosadienoyl-sn-glycero-3-phosphoethanolamine

C43H82NO7P (755.5828592)


   

Glucosylceramide (d18:1/20:0)

Glucosylceramide (d18:1/20:0)

C44H85NO8 (755.627485)


   

PC(P-18:0/17:2(9Z,12Z))

1-(1Z-octadecenyl)-2-(9Z,12Z-heptadecadienoyl)-glycero-3-phosphocholine

C43H82NO7P (755.5828592)


   

PE(O-18:0/20:3(8Z,11Z,14Z))

1-octadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-glycero-3-phosphoethanolamine

C43H82NO7P (755.5828592)


   

PE(O-20:0/18:3(6Z,9Z,12Z))

1-eicosyl-2-(6Z,9Z,12Z-octadecatrienoyl)-glycero-3-phosphoethanolamine

C43H82NO7P (755.5828592)


   

PE(O-20:0/18:3(9Z,12Z,15Z))

1-eicosyl-2-(9Z,12Z,15Z-octadecatrienoyl)-glycero-3-phosphoethanolamine

C43H82NO7P (755.5828592)


   

PE(P-20:0/18:2(9Z,12Z))

1-(1Z-eicosenyl)-2-(9Z,12Z-octadecadienoyl)-glycero-3-phosphoethanolamine

C43H82NO7P (755.5828592)


   

PC O-35:3

1-(1Z-octadecenyl)-2-(9Z,12Z-heptadecadienoyl)-glycero-3-phosphocholine

C43H82NO7P (755.5828592)


   

PE O-38:3

1-(1Z-octadecenyl)-2-(11Z,14Z-eicosadienoyl)-glycero-3-phosphoethanolamine

C43H82NO7P (755.5828592)


   

C26:1 CerP

N-(17Z-hexacosenoyl)-sphing-4-enine-1-phosphate

C44H86NO6P (755.6192426)


   

HexCer 37:2;O3

N-(2S-hydroxy-octadecanoyl)-1-beta-glucosyl-4E,8E-9-methyl-octadecasphingadienine

C43H81NO9 (755.5911016)


   

Allantoside

N-(2R-hydroxy-pentadecanoyl)-1-beta-glucosyl-9-methyl-heneicosasphing-4E,8E-dienine

C43H81NO9 (755.5911016)


   

Flavicerebroside A

N-(2R-hydroxy-octadecanoyl)-1-beta-D-galactosyl-9-methyl-sphing-4E,8E-dienine

C43H81NO9 (755.5911016)


   

Flavuside A

N-(2R-hydroxy-octadecanoyl)-1-beta-glucosyl-10-methyl-sphinga-4E,9E-dienine

C43H81NO9 (755.5911016)


   

HexCer 38:1;O2

N-(tetracosanoyl)-1-beta-glucosyl-tetradecasphing-4-enine

C44H85NO8 (755.627485)


   
   

N-[(2S,3R,4E)-1-(beta-D-galactopyranosyloxy)-3-hydroxyhexadec-4-en-2-yl]docosanamide

N-[(2S,3R,4E)-1-(beta-D-galactopyranosyloxy)-3-hydroxyhexadec-4-en-2-yl]docosanamide

C44H85NO8 (755.627485)


   

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

N-[(2S,3R,4E)-1-(beta-D-glucopyranosyloxy)-3-hydroxyhexadec-4-en-2-yl]docosanamide

N-[(2S,3R,4E)-1-(beta-D-glucopyranosyloxy)-3-hydroxyhexadec-4-en-2-yl]docosanamide

C44H85NO8 (755.627485)


   

beta-D-galactosyl-N-eicosanoylsphingosine

beta-D-galactosyl-N-eicosanoylsphingosine

C44H85NO8 (755.627485)


A beta-D-galactosyl-N-acylsphingosine in which the acyl group is specified as eicosanoyl.

   

beta-D-glucosyl-(1<->1)-N-henicosanoyl-14-methylhexadecasphingosine

beta-D-glucosyl-(1<->1)-N-henicosanoyl-14-methylhexadecasphingosine

C44H85NO8 (755.627485)


A beta-D-glucosylceramide in which a beta-D-glucosyl residue attached to the primary hydroxyl group of N-henicosanoyl-14-methylhexadecasphingosine. It is a metabolite of the nematode Caenorhabditis elegans.

   

PE(20:1(11Z)/P-18:1(9Z))

PE(20:1(11Z)/P-18:1(9Z))

C43H82NO7P (755.5828592)


   

PE(20:1(11Z)/P-18:1(11Z))

PE(20:1(11Z)/P-18:1(11Z))

C43H82NO7P (755.5828592)


   

N-hexacosanoylsphingosine 1-phosphate(2-)

N-hexacosanoylsphingosine 1-phosphate(2-)

C44H86NO6P-2 (755.6192426)


   

N-henicosanoyl-1-O-beta-D-glucosyl-15-methylhexadecasphing-4-enine

N-henicosanoyl-1-O-beta-D-glucosyl-15-methylhexadecasphing-4-enine

C44H85NO8 (755.627485)


   

2-[hydroxy-[(2S,3R,4E,14Z)-3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]octadeca-4,14-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R,4E,14Z)-3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]octadeca-4,14-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

HexCer 18:1;2O/20:0

HexCer 18:1;2O/20:0

C44H85NO8 (755.627485)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propan-2-yl] (Z)-icos-11-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propan-2-yl] (Z)-icos-11-enoate

C43H82NO7P (755.5828592)


   

HexCer 33:1;2O/5:0

HexCer 33:1;2O/5:0

C44H85NO8 (755.627485)


   

HexCer 8:1;2O/30:0

HexCer 8:1;2O/30:0

C44H85NO8 (755.627485)


   

HexCer 34:1;2O/4:0

HexCer 34:1;2O/4:0

C44H85NO8 (755.627485)


   

HexCer 32:1;2O/6:0

HexCer 32:1;2O/6:0

C44H85NO8 (755.627485)


   

HexCer 8:0;2O/30:1

HexCer 8:0;2O/30:1

C44H85NO8 (755.627485)


   

HexCer 35:1;2O/3:0

HexCer 35:1;2O/3:0

C44H85NO8 (755.627485)


   

HexCer 30:1;2O/8:0

HexCer 30:1;2O/8:0

C44H85NO8 (755.627485)


   

HexCer 29:1;2O/9:0

HexCer 29:1;2O/9:0

C44H85NO8 (755.627485)


   

HexCer 31:1;2O/7:0

HexCer 31:1;2O/7:0

C44H85NO8 (755.627485)


   

HexCer 9:1;2O/29:0

HexCer 9:1;2O/29:0

C44H85NO8 (755.627485)


   

HexCer 36:1;2O/2:0

HexCer 36:1;2O/2:0

C44H85NO8 (755.627485)


   

HexCer 17:0;2O/21:1

HexCer 17:0;2O/21:1

C44H85NO8 (755.627485)


   

HexCer 11:1;2O/27:0

HexCer 11:1;2O/27:0

C44H85NO8 (755.627485)


   

HexCer 22:0;2O/16:1

HexCer 22:0;2O/16:1

C44H85NO8 (755.627485)


   

HexCer 14:0;2O/24:1

HexCer 14:0;2O/24:1

C44H85NO8 (755.627485)


   

HexCer 27:1;2O/11:0

HexCer 27:1;2O/11:0

C44H85NO8 (755.627485)


   

HexCer 10:1;2O/28:0

HexCer 10:1;2O/28:0

C44H85NO8 (755.627485)


   

HexCer 28:1;2O/10:0

HexCer 28:1;2O/10:0

C44H85NO8 (755.627485)


   

HexCer 13:1;2O/25:0

HexCer 13:1;2O/25:0

C44H85NO8 (755.627485)


   

HexCer 16:0;2O/22:1

HexCer 16:0;2O/22:1

C44H85NO8 (755.627485)


   

HexCer 10:0;2O/28:1

HexCer 10:0;2O/28:1

C44H85NO8 (755.627485)


   

HexCer 25:0;2O/13:1

HexCer 25:0;2O/13:1

C44H85NO8 (755.627485)


   

HexCer 12:1;2O/26:0

HexCer 12:1;2O/26:0

C44H85NO8 (755.627485)


   

HexCer 21:0;2O/17:1

HexCer 21:0;2O/17:1

C44H85NO8 (755.627485)


   

HexCer 20:0;2O/18:1

HexCer 20:0;2O/18:1

C44H85NO8 (755.627485)


   

HexCer 12:0;2O/26:1

HexCer 12:0;2O/26:1

C44H85NO8 (755.627485)


   

HexCer 21:2;2O/16:0;O

HexCer 21:2;2O/16:0;O

C43H81NO9 (755.5911016)


   

HexCer 20:1;2O/17:1;O

HexCer 20:1;2O/17:1;O

C43H81NO9 (755.5911016)


   

HexCer 19:1;2O/18:1;O

HexCer 19:1;2O/18:1;O

C43H81NO9 (755.5911016)


   

HexCer 18:2;2O/19:0;O

HexCer 18:2;2O/19:0;O

C43H81NO9 (755.5911016)


   

HexCer 20:2;2O/17:0;O

HexCer 20:2;2O/17:0;O

C43H81NO9 (755.5911016)


   

HexCer 21:1;2O/16:1;O

HexCer 21:1;2O/16:1;O

C43H81NO9 (755.5911016)


   

HexCer 22:1;2O/15:1;O

HexCer 22:1;2O/15:1;O

C43H81NO9 (755.5911016)


   

HexCer 18:1;2O/19:1;O

HexCer 18:1;2O/19:1;O

C43H81NO9 (755.5911016)


   

HexCer 17:2;2O/20:0;O

HexCer 17:2;2O/20:0;O

C43H81NO9 (755.5911016)


   

HexCer 16:2;2O/21:0;O

HexCer 16:2;2O/21:0;O

C43H81NO9 (755.5911016)


   

HexCer 17:1;2O/20:1;O

HexCer 17:1;2O/20:1;O

C43H81NO9 (755.5911016)


   

HexCer 19:0;2O/18:2;O

HexCer 19:0;2O/18:2;O

C43H81NO9 (755.5911016)


   

HexCer 16:1;2O/21:1;O

HexCer 16:1;2O/21:1;O

C43H81NO9 (755.5911016)


   

HexCer 17:0;2O/20:2;O

HexCer 17:0;2O/20:2;O

C43H81NO9 (755.5911016)


   

HexCer 19:2;2O/18:0;O

HexCer 19:2;2O/18:0;O

C43H81NO9 (755.5911016)


   

HexCer 22:2;2O/15:0;O

HexCer 22:2;2O/15:0;O

C43H81NO9 (755.5911016)


   

HexCer 21:0;2O/16:2;O

HexCer 21:0;2O/16:2;O

C43H81NO9 (755.5911016)


   

[2-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]oxy-3-nonoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]oxy-3-nonoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H82NO7P (755.5828592)


   

2-(3-Nonanoyloxy-2-pentacosanoyloxypropoxy)-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-(3-Nonanoyloxy-2-pentacosanoyloxypropoxy)-2-[2-(trimethylazaniumyl)ethoxy]acetate

C44H85NO8 (755.627485)


   

(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-[(4E,8E)-1,3-dihydroxyheptadeca-4,8-dien-2-yl]tetratriaconta-7,10,13,16,19,22,25,28,31-nonaenamide

(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-[(4E,8E)-1,3-dihydroxyheptadeca-4,8-dien-2-yl]tetratriaconta-7,10,13,16,19,22,25,28,31-nonaenamide

C51H81NO3 (755.6216115999999)


   

(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E,12E)-1,3-dihydroxyhenicosa-4,8,12-trien-2-yl]triaconta-6,9,12,15,18,21,24,27-octaenamide

(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E,12E)-1,3-dihydroxyhenicosa-4,8,12-trien-2-yl]triaconta-6,9,12,15,18,21,24,27-octaenamide

C51H81NO3 (755.6216115999999)


   

(12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z,36Z,39Z)-N-[(E)-1,3-dihydroxynon-4-en-2-yl]dotetraconta-12,15,18,21,24,27,30,33,36,39-decaenamide

(12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z,36Z,39Z)-N-[(E)-1,3-dihydroxynon-4-en-2-yl]dotetraconta-12,15,18,21,24,27,30,33,36,39-decaenamide

C51H81NO3 (755.6216115999999)


   

(9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-[(4E,8E)-1,3-dihydroxypentadeca-4,8-dien-2-yl]hexatriaconta-9,12,15,18,21,24,27,30,33-nonaenamide

(9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-[(4E,8E)-1,3-dihydroxypentadeca-4,8-dien-2-yl]hexatriaconta-9,12,15,18,21,24,27,30,33-nonaenamide

C51H81NO3 (755.6216115999999)


   

(12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-[(4E,8E,12E)-1,3-dihydroxypentadeca-4,8,12-trien-2-yl]hexatriaconta-12,15,18,21,24,27,30,33-octaenamide

(12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-[(4E,8E,12E)-1,3-dihydroxypentadeca-4,8,12-trien-2-yl]hexatriaconta-12,15,18,21,24,27,30,33-octaenamide

C51H81NO3 (755.6216115999999)


   

(5Z,8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(4E,8E)-1,3-dihydroxynonadeca-4,8-dien-2-yl]dotriaconta-5,8,11,14,17,20,23,26,29-nonaenamide

(5Z,8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(4E,8E)-1,3-dihydroxynonadeca-4,8-dien-2-yl]dotriaconta-5,8,11,14,17,20,23,26,29-nonaenamide

C51H81NO3 (755.6216115999999)


   

2-(2-Hexacosanoyloxy-3-octanoyloxypropoxy)-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-(2-Hexacosanoyloxy-3-octanoyloxypropoxy)-2-[2-(trimethylazaniumyl)ethoxy]acetate

C44H85NO8 (755.627485)


   

(9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z,36Z,39Z)-N-(1,3-dihydroxynonan-2-yl)dotetraconta-9,12,15,18,21,24,27,30,33,36,39-undecaenamide

(9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z,36Z,39Z)-N-(1,3-dihydroxynonan-2-yl)dotetraconta-9,12,15,18,21,24,27,30,33,36,39-undecaenamide

C51H81NO3 (755.6216115999999)


   

(11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-N-[(4E,8E)-1,3-dihydroxytrideca-4,8-dien-2-yl]octatriaconta-11,14,17,20,23,26,29,32,35-nonaenamide

(11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-N-[(4E,8E)-1,3-dihydroxytrideca-4,8-dien-2-yl]octatriaconta-11,14,17,20,23,26,29,32,35-nonaenamide

C51H81NO3 (755.6216115999999)


   

(10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-[(4E,8E,12E)-1,3-dihydroxyheptadeca-4,8,12-trien-2-yl]tetratriaconta-10,13,16,19,22,25,28,31-octaenamide

(10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-[(4E,8E,12E)-1,3-dihydroxyheptadeca-4,8,12-trien-2-yl]tetratriaconta-10,13,16,19,22,25,28,31-octaenamide

C51H81NO3 (755.6216115999999)


   

(8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(4E,8E,12E)-1,3-dihydroxynonadeca-4,8,12-trien-2-yl]dotriaconta-8,11,14,17,20,23,26,29-octaenamide

(8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(4E,8E,12E)-1,3-dihydroxynonadeca-4,8,12-trien-2-yl]dotriaconta-8,11,14,17,20,23,26,29-octaenamide

C51H81NO3 (755.6216115999999)


   

2-(2-Nonadecanoyloxy-3-pentadecanoyloxypropoxy)-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-(2-Nonadecanoyloxy-3-pentadecanoyloxypropoxy)-2-[2-(trimethylazaniumyl)ethoxy]acetate

C44H85NO8 (755.627485)


   

2-(2-Icosanoyloxy-3-tetradecanoyloxypropoxy)-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-(2-Icosanoyloxy-3-tetradecanoyloxypropoxy)-2-[2-(trimethylazaniumyl)ethoxy]acetate

C44H85NO8 (755.627485)


   

2-(2-Henicosanoyloxy-3-tridecanoyloxypropoxy)-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-(2-Henicosanoyloxy-3-tridecanoyloxypropoxy)-2-[2-(trimethylazaniumyl)ethoxy]acetate

C44H85NO8 (755.627485)


   

2-(3-Hexadecanoyloxy-2-octadecanoyloxypropoxy)-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-(3-Hexadecanoyloxy-2-octadecanoyloxypropoxy)-2-[2-(trimethylazaniumyl)ethoxy]acetate

C44H85NO8 (755.627485)


   

2-(2-Tricosanoyloxy-3-undecanoyloxypropoxy)-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-(2-Tricosanoyloxy-3-undecanoyloxypropoxy)-2-[2-(trimethylazaniumyl)ethoxy]acetate

C44H85NO8 (755.627485)


   

2-(2-Docosanoyloxy-3-dodecanoyloxypropoxy)-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-(2-Docosanoyloxy-3-dodecanoyloxypropoxy)-2-[2-(trimethylazaniumyl)ethoxy]acetate

C44H85NO8 (755.627485)


   

2-(3-Decanoyloxy-2-tetracosanoyloxypropoxy)-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-(3-Decanoyloxy-2-tetracosanoyloxypropoxy)-2-[2-(trimethylazaniumyl)ethoxy]acetate

C44H85NO8 (755.627485)


   

2-[2,3-Di(heptadecanoyloxy)propoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-[2,3-Di(heptadecanoyloxy)propoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C44H85NO8 (755.627485)


   

(10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(E)-1,3-dihydroxyundec-4-en-2-yl]tetraconta-10,13,16,19,22,25,28,31,34,37-decaenamide

(10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(E)-1,3-dihydroxyundec-4-en-2-yl]tetraconta-10,13,16,19,22,25,28,31,34,37-decaenamide

C51H81NO3 (755.6216115999999)


   

(8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-N-[(E)-1,3-dihydroxytridec-4-en-2-yl]octatriaconta-8,11,14,17,20,23,26,29,32,35-decaenamide

(8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-N-[(E)-1,3-dihydroxytridec-4-en-2-yl]octatriaconta-8,11,14,17,20,23,26,29,32,35-decaenamide

C51H81NO3 (755.6216115999999)


   

(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-[(E)-1,3-dihydroxypentadec-4-en-2-yl]hexatriaconta-6,9,12,15,18,21,24,27,30,33-decaenamide

(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-[(E)-1,3-dihydroxypentadec-4-en-2-yl]hexatriaconta-6,9,12,15,18,21,24,27,30,33-decaenamide

C51H81NO3 (755.6216115999999)


   

(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-(1,3-dihydroxyundecan-2-yl)tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide

(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-(1,3-dihydroxyundecan-2-yl)tetraconta-7,10,13,16,19,22,25,28,31,34,37-undecaenamide

C51H81NO3 (755.6216115999999)


   

(E)-3-hydroxy-2-[[(Z)-2-hydroxyoctadec-11-enoyl]amino]hexacos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(Z)-2-hydroxyoctadec-11-enoyl]amino]hexacos-4-ene-1-sulfonic acid

C44H85NO6S (755.609727)


   

(4E,8E)-3-hydroxy-2-(2-hydroxyicosanoylamino)tetracosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-(2-hydroxyicosanoylamino)tetracosa-4,8-diene-1-sulfonic acid

C44H85NO6S (755.609727)


   

(4E,8E)-3-hydroxy-2-(2-hydroxynonadecanoylamino)pentacosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-(2-hydroxynonadecanoylamino)pentacosa-4,8-diene-1-sulfonic acid

C44H85NO6S (755.609727)


   

(4E,8E)-3-hydroxy-2-(2-hydroxyhexacosanoylamino)octadeca-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-(2-hydroxyhexacosanoylamino)octadeca-4,8-diene-1-sulfonic acid

C44H85NO6S (755.609727)


   

(E)-3-hydroxy-2-[[(Z)-2-hydroxydocos-11-enoyl]amino]docos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(Z)-2-hydroxydocos-11-enoyl]amino]docos-4-ene-1-sulfonic acid

C44H85NO6S (755.609727)


   

3-hydroxy-2-[[(11Z,14Z)-2-hydroxyicosa-11,14-dienoyl]amino]tetracosane-1-sulfonic acid

3-hydroxy-2-[[(11Z,14Z)-2-hydroxyicosa-11,14-dienoyl]amino]tetracosane-1-sulfonic acid

C44H85NO6S (755.609727)


   

(4E,8E)-3-hydroxy-2-(2-hydroxyoctadecanoylamino)hexacosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-(2-hydroxyoctadecanoylamino)hexacosa-4,8-diene-1-sulfonic acid

C44H85NO6S (755.609727)


   

3-hydroxy-2-[[(10Z,12Z)-2-hydroxyoctadeca-10,12-dienoyl]amino]hexacosane-1-sulfonic acid

3-hydroxy-2-[[(10Z,12Z)-2-hydroxyoctadeca-10,12-dienoyl]amino]hexacosane-1-sulfonic acid

C44H85NO6S (755.609727)


   

3-hydroxy-2-[[(11Z,14Z)-2-hydroxyhexacosa-11,14-dienoyl]amino]octadecane-1-sulfonic acid

3-hydroxy-2-[[(11Z,14Z)-2-hydroxyhexacosa-11,14-dienoyl]amino]octadecane-1-sulfonic acid

C44H85NO6S (755.609727)


   

(E)-3-hydroxy-2-[[(Z)-2-hydroxytricos-11-enoyl]amino]henicos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(Z)-2-hydroxytricos-11-enoyl]amino]henicos-4-ene-1-sulfonic acid

C44H85NO6S (755.609727)


   

(E)-3-hydroxy-2-[[(Z)-2-hydroxypentacos-11-enoyl]amino]nonadec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(Z)-2-hydroxypentacos-11-enoyl]amino]nonadec-4-ene-1-sulfonic acid

C44H85NO6S (755.609727)


   

(E)-3-hydroxy-2-[[(Z)-2-hydroxytetracos-11-enoyl]amino]icos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(Z)-2-hydroxytetracos-11-enoyl]amino]icos-4-ene-1-sulfonic acid

C44H85NO6S (755.609727)


   

(4E,8E)-3-hydroxy-2-(2-hydroxydocosanoylamino)docosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-(2-hydroxydocosanoylamino)docosa-4,8-diene-1-sulfonic acid

C44H85NO6S (755.609727)


   

(E)-3-hydroxy-2-[[(Z)-2-hydroxyhenicos-9-enoyl]amino]tricos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(Z)-2-hydroxyhenicos-9-enoyl]amino]tricos-4-ene-1-sulfonic acid

C44H85NO6S (755.609727)


   

(4E,8E)-3-hydroxy-2-(2-hydroxypentacosanoylamino)nonadeca-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-(2-hydroxypentacosanoylamino)nonadeca-4,8-diene-1-sulfonic acid

C44H85NO6S (755.609727)


   

3-hydroxy-2-[[(18Z,21Z)-2-hydroxytetracosa-18,21-dienoyl]amino]icosane-1-sulfonic acid

3-hydroxy-2-[[(18Z,21Z)-2-hydroxytetracosa-18,21-dienoyl]amino]icosane-1-sulfonic acid

C44H85NO6S (755.609727)


   

(E)-3-hydroxy-2-[[(Z)-2-hydroxynonadec-9-enoyl]amino]pentacos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(Z)-2-hydroxynonadec-9-enoyl]amino]pentacos-4-ene-1-sulfonic acid

C44H85NO6S (755.609727)


   

(E)-3-hydroxy-2-[[(Z)-2-hydroxyhexacos-11-enoyl]amino]octadec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(Z)-2-hydroxyhexacos-11-enoyl]amino]octadec-4-ene-1-sulfonic acid

C44H85NO6S (755.609727)


   

(4E,8E)-3-hydroxy-2-(2-hydroxytricosanoylamino)henicosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-(2-hydroxytricosanoylamino)henicosa-4,8-diene-1-sulfonic acid

C44H85NO6S (755.609727)


   

3-hydroxy-2-[[(14Z,16Z)-2-hydroxydocosa-14,16-dienoyl]amino]docosane-1-sulfonic acid

3-hydroxy-2-[[(14Z,16Z)-2-hydroxydocosa-14,16-dienoyl]amino]docosane-1-sulfonic acid

C44H85NO6S (755.609727)


   

(E)-3-hydroxy-2-[[(Z)-2-hydroxyicos-11-enoyl]amino]tetracos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(Z)-2-hydroxyicos-11-enoyl]amino]tetracos-4-ene-1-sulfonic acid

C44H85NO6S (755.609727)


   

(4E,8E)-3-hydroxy-2-(2-hydroxyhenicosanoylamino)tricosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-(2-hydroxyhenicosanoylamino)tricosa-4,8-diene-1-sulfonic acid

C44H85NO6S (755.609727)


   

(4E,8E)-3-hydroxy-2-(2-hydroxytetracosanoylamino)icosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-(2-hydroxytetracosanoylamino)icosa-4,8-diene-1-sulfonic acid

C44H85NO6S (755.609727)


   

[3-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoxy]-2-nonanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoxy]-2-nonanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H82NO7P (755.5828592)


   

[2-heptanoyloxy-3-[(14Z,17Z,20Z)-octacosa-14,17,20-trienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-heptanoyloxy-3-[(14Z,17Z,20Z)-octacosa-14,17,20-trienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H82NO7P (755.5828592)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-henicos-11-enoxy]propan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-henicos-11-enoxy]propan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C43H82NO7P (755.5828592)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-icos-11-enoxy]propan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-icos-11-enoxy]propan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

C43H82NO7P (755.5828592)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propan-2-yl] (Z)-tetradec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propan-2-yl] (Z)-tetradec-9-enoate

C43H82NO7P (755.5828592)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-decoxypropan-2-yl] (14Z,17Z,20Z)-octacosa-14,17,20-trienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-decoxypropan-2-yl] (14Z,17Z,20Z)-octacosa-14,17,20-trienoate

C43H82NO7P (755.5828592)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-nonadec-9-enoxy]propan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-nonadec-9-enoxy]propan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

C43H82NO7P (755.5828592)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-icosoxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-icosoxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C43H82NO7P (755.5828592)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propan-2-yl] docosanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propan-2-yl] docosanoate

C43H82NO7P (755.5828592)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-docos-13-enoxy]propan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-docos-13-enoxy]propan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C43H82NO7P (755.5828592)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propan-2-yl] (Z)-henicos-11-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propan-2-yl] (Z)-henicos-11-enoate

C43H82NO7P (755.5828592)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propan-2-yl] (Z)-octadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propan-2-yl] (Z)-octadec-9-enoate

C43H82NO7P (755.5828592)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-docosoxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-docosoxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C43H82NO7P (755.5828592)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoxy]propan-2-yl] tetradecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoxy]propan-2-yl] tetradecanoate

C43H82NO7P (755.5828592)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-heptadec-9-enoxy]propan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-heptadec-9-enoxy]propan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

C43H82NO7P (755.5828592)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-henicosa-11,14-dienoxy]propan-2-yl] (Z)-heptadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-henicosa-11,14-dienoxy]propan-2-yl] (Z)-heptadec-9-enoate

C43H82NO7P (755.5828592)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecoxypropan-2-yl] (10Z,13Z,16Z)-tetracosa-10,13,16-trienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecoxypropan-2-yl] (10Z,13Z,16Z)-tetracosa-10,13,16-trienoate

C43H82NO7P (755.5828592)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13Z,16Z)-docosa-13,16-dienoxy]propan-2-yl] (Z)-hexadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13Z,16Z)-docosa-13,16-dienoxy]propan-2-yl] (Z)-hexadec-9-enoate

C43H82NO7P (755.5828592)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoxy]propan-2-yl] dodecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoxy]propan-2-yl] dodecanoate

C43H82NO7P (755.5828592)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(14Z,17Z,20Z)-octacosa-14,17,20-trienoxy]propan-2-yl] decanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(14Z,17Z,20Z)-octacosa-14,17,20-trienoxy]propan-2-yl] decanoate

C43H82NO7P (755.5828592)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecoxypropan-2-yl] (12Z,15Z,18Z)-hexacosa-12,15,18-trienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecoxypropan-2-yl] (12Z,15Z,18Z)-hexacosa-12,15,18-trienoate

C43H82NO7P (755.5828592)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propan-2-yl] (Z)-nonadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propan-2-yl] (Z)-nonadec-9-enoate

C43H82NO7P (755.5828592)


   

[3-[(11Z,14Z)-icosa-11,14-dienoxy]-2-[(Z)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(11Z,14Z)-icosa-11,14-dienoxy]-2-[(Z)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H82NO7P (755.5828592)


   

[2-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxy-3-tridecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxy-3-tridecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H82NO7P (755.5828592)


   

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-[(Z)-nonadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-[(Z)-nonadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H82NO7P (755.5828592)


   

[3-[(Z)-heptadec-9-enoxy]-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(Z)-heptadec-9-enoxy]-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H82NO7P (755.5828592)


   

[2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxy-3-pentadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxy-3-pentadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H82NO7P (755.5828592)


   

[2-[(Z)-hexadec-9-enoyl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-hexadec-9-enoyl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H82NO7P (755.5828592)


   

[2-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]oxy-3-undecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]oxy-3-undecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H82NO7P (755.5828592)


   

[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-nonadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-nonadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H82NO7P (755.5828592)


   

[3-[(11Z,14Z)-henicosa-11,14-dienoxy]-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(11Z,14Z)-henicosa-11,14-dienoxy]-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H82NO7P (755.5828592)


   

[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-2-nonadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-2-nonadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H82NO7P (755.5828592)


   

[3-[(13Z,16Z)-docosa-13,16-dienoxy]-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(13Z,16Z)-docosa-13,16-dienoxy]-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H82NO7P (755.5828592)


   

[3-heptadecoxy-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-heptadecoxy-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H82NO7P (755.5828592)


   

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-[(Z)-pentadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-[(Z)-pentadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H82NO7P (755.5828592)


   

[3-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoxy]-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoxy]-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H82NO7P (755.5828592)


   

[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-[(Z)-tridec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-[(Z)-tridec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H82NO7P (755.5828592)


   

[3-[(9Z,12Z)-heptadeca-9,12-dienoxy]-2-[(Z)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(9Z,12Z)-heptadeca-9,12-dienoxy]-2-[(Z)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H82NO7P (755.5828592)


   

2-[4-[3-[(Z)-henicos-11-enoyl]oxy-12-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid

2-[4-[3-[(Z)-henicos-11-enoyl]oxy-12-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid

C47H81NO6 (755.6063566)


   

HexCer 16:1;2O/22:0

HexCer 16:1;2O/22:0

C44H85NO8 (755.627485)


   

HexCer 24:0;2O/14:1

HexCer 24:0;2O/14:1

C44H85NO8 (755.627485)


   

HexCer 15:1;2O/23:0

HexCer 15:1;2O/23:0

C44H85NO8 (755.627485)


   

HexCer 19:0;2O/19:1

HexCer 19:0;2O/19:1

C44H85NO8 (755.627485)


   

HexCer 14:1;2O/24:0

HexCer 14:1;2O/24:0

C44H85NO8 (755.627485)


   

HexCer 21:1;2O/17:0

HexCer 21:1;2O/17:0

C44H85NO8 (755.627485)


   

HexCer 24:1;2O/14:0

HexCer 24:1;2O/14:0

C44H85NO8 (755.627485)


   

HexCer 17:1;2O/21:0

HexCer 17:1;2O/21:0

C44H85NO8 (755.627485)


   

HexCer 23:0;2O/15:1

HexCer 23:0;2O/15:1

C44H85NO8 (755.627485)


   

HexCer 25:1;2O/13:0

HexCer 25:1;2O/13:0

C44H85NO8 (755.627485)


   

HexCer 23:1;2O/15:0

HexCer 23:1;2O/15:0

C44H85NO8 (755.627485)


   

HexCer 22:1;2O/16:0

HexCer 22:1;2O/16:0

C44H85NO8 (755.627485)


   

HexCer 20:1;2O/18:0

HexCer 20:1;2O/18:0

C44H85NO8 (755.627485)


   

HexCer 26:1;2O/12:0

HexCer 26:1;2O/12:0

C44H85NO8 (755.627485)


   

HexCer 18:0;2O/20:1

HexCer 18:0;2O/20:1

C44H85NO8 (755.627485)


   

HexCer 19:1;2O/19:0

HexCer 19:1;2O/19:0

C44H85NO8 (755.627485)


   

[3-[(Z)-hexadec-9-enoxy]-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(Z)-hexadec-9-enoxy]-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H82NO7P (755.5828592)


   

[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-[(Z)-nonadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-[(Z)-nonadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H82NO7P (755.5828592)


   

[3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]-2-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]-2-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H82NO7P (755.5828592)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecoxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecoxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C43H82NO7P (755.5828592)


   

[2-[(Z)-heptadec-9-enoyl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-heptadec-9-enoyl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H82NO7P (755.5828592)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]propan-2-yl] hexadecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]propan-2-yl] hexadecanoate

C43H82NO7P (755.5828592)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate

C43H82NO7P (755.5828592)


   

[2-heptadecanoyloxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-heptadecanoyloxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H82NO7P (755.5828592)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexadec-9-enoxy]propan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexadec-9-enoxy]propan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

C43H82NO7P (755.5828592)


   

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-[(Z)-tetradec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-[(Z)-tetradec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H82NO7P (755.5828592)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propan-2-yl] (Z)-docos-13-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propan-2-yl] (Z)-docos-13-enoate

C43H82NO7P (755.5828592)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

C43H82NO7P (755.5828592)


   

[3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]-2-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]-2-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H82NO7P (755.5828592)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propan-2-yl] icosanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propan-2-yl] icosanoate

C43H82NO7P (755.5828592)


   

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-[(Z)-octadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-[(Z)-octadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H82NO7P (755.5828592)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]propan-2-yl] octadecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]propan-2-yl] octadecanoate

C43H82NO7P (755.5828592)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecoxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecoxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C43H82NO7P (755.5828592)


   

(Z)-N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentadecan-2-yl]tricos-11-enamide

(Z)-N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentadecan-2-yl]tricos-11-enamide

C44H85NO8 (755.627485)


   

(Z)-N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexacosan-2-yl]dodec-5-enamide

(Z)-N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexacosan-2-yl]dodec-5-enamide

C44H85NO8 (755.627485)


   

(Z)-N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadecan-2-yl]docos-11-enamide

(Z)-N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadecan-2-yl]docos-11-enamide

C44H85NO8 (755.627485)


   

(Z)-N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocosan-2-yl]hexadec-7-enamide

(Z)-N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocosan-2-yl]hexadec-7-enamide

C44H85NO8 (755.627485)


   

(Z)-N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicosan-2-yl]octadec-11-enamide

(Z)-N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicosan-2-yl]octadec-11-enamide

C44H85NO8 (755.627485)


   

(Z)-N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentacosan-2-yl]tridec-8-enamide

(Z)-N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentacosan-2-yl]tridec-8-enamide

C44H85NO8 (755.627485)


   

(Z)-N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradecan-2-yl]tetracos-11-enamide

(Z)-N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradecan-2-yl]tetracos-11-enamide

C44H85NO8 (755.627485)


   

(Z)-N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptadecan-2-yl]henicos-9-enamide

(Z)-N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptadecan-2-yl]henicos-9-enamide

C44H85NO8 (755.627485)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (24Z,27Z,30Z)-octatriaconta-24,27,30-trienoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (24Z,27Z,30Z)-octatriaconta-24,27,30-trienoate

C43H82NO7P (755.5828592)


   
   

[(E,2S,3R)-2-[[(E)-hexacos-17-enoyl]amino]-3-hydroxyoctadec-4-enyl] dihydrogen phosphate

[(E,2S,3R)-2-[[(E)-hexacos-17-enoyl]amino]-3-hydroxyoctadec-4-enyl] dihydrogen phosphate

C44H86NO6P (755.6192426)


   

N-(heptadecanoyl)-1-beta-glucosyl-4E-heneicosasphingenine

N-(heptadecanoyl)-1-beta-glucosyl-4E-heneicosasphingenine

C44H85NO8 (755.627485)


   

N-(hexadecanoyl)-1-beta-glucosyl-4E-docosasphingenine

N-(hexadecanoyl)-1-beta-glucosyl-4E-docosasphingenine

C44H85NO8 (755.627485)


   

N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentadec-4-en-2-yl]tricosanamide

N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentadec-4-en-2-yl]tricosanamide

C44H85NO8 (755.627485)


   

N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptadec-8-en-2-yl]henicosanamide

N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptadec-8-en-2-yl]henicosanamide

C44H85NO8 (755.627485)


   

N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]icosanamide

N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]icosanamide

C44H85NO8 (755.627485)


   

N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxynonadec-8-en-2-yl]nonadecanamide

N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxynonadec-8-en-2-yl]nonadecanamide

C44H85NO8 (755.627485)


   

2-[hydroxy-[(2S,3R,4E,14E)-3-hydroxy-2-[[(E)-icos-11-enoyl]amino]octadeca-4,14-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R,4E,14E)-3-hydroxy-2-[[(E)-icos-11-enoyl]amino]octadeca-4,14-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-icos-1-enoxy]propan-2-yl] (6E,9E)-octadeca-6,9-dienoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-icos-1-enoxy]propan-2-yl] (6E,9E)-octadeca-6,9-dienoate

C43H82NO7P (755.5828592)


   

N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradec-4-en-2-yl]tetracosanamide

N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradec-4-en-2-yl]tetracosanamide

C44H85NO8 (755.627485)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-1-enoxy]propan-2-yl] (11E,14E)-icosa-11,14-dienoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-1-enoxy]propan-2-yl] (11E,14E)-icosa-11,14-dienoate

C43H82NO7P (755.5828592)


   

N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptadec-4-en-2-yl]henicosanamide

N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptadec-4-en-2-yl]henicosanamide

C44H85NO8 (755.627485)


   

N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadec-4-en-2-yl]docosanamide

N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadec-4-en-2-yl]docosanamide

C44H85NO8 (755.627485)


   

N-[(E,2S,3R)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocos-8-en-2-yl]hexadecanamide

N-[(E,2S,3R)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocos-8-en-2-yl]hexadecanamide

C44H85NO8 (755.627485)


   

(E)-N-[(2S,3R)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocosan-2-yl]hexadec-9-enamide

(E)-N-[(2S,3R)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocosan-2-yl]hexadec-9-enamide

C44H85NO8 (755.627485)


   

N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-8-en-2-yl]icosanamide

N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-8-en-2-yl]icosanamide

C44H85NO8 (755.627485)


   

N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadec-8-en-2-yl]docosanamide

N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadec-8-en-2-yl]docosanamide

C44H85NO8 (755.627485)


   

2-[[(2S,3R,4E,6E)-2-[[(E)-docos-13-enoyl]amino]-3-hydroxyhexadeca-4,6-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2S,3R,4E,6E)-2-[[(E)-docos-13-enoyl]amino]-3-hydroxyhexadeca-4,6-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-1-enoxy]propan-2-yl] (5E,8E)-icosa-5,8-dienoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-1-enoxy]propan-2-yl] (5E,8E)-icosa-5,8-dienoate

C43H82NO7P (755.5828592)


   

2-[hydroxy-[(2S,3R,4E,6E)-3-hydroxy-2-[[(E)-tetracos-15-enoyl]amino]tetradeca-4,6-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R,4E,6E)-3-hydroxy-2-[[(E)-tetracos-15-enoyl]amino]tetradeca-4,6-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-1-enoxy]propan-2-yl] (13E,16E)-docosa-13,16-dienoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-1-enoxy]propan-2-yl] (13E,16E)-docosa-13,16-dienoate

C43H82NO7P (755.5828592)


   

N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicos-8-en-2-yl]octadecanamide

N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicos-8-en-2-yl]octadecanamide

C44H85NO8 (755.627485)


   

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(9E,12E)-octadeca-9,12-dienoyl]amino]icos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(9E,12E)-octadeca-9,12-dienoyl]amino]icos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-[[(E)-tetracos-15-enoyl]amino]tetradeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-[[(E)-tetracos-15-enoyl]amino]tetradeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-[[(E)-octadec-9-enoyl]amino]icosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-[[(E)-octadec-9-enoyl]amino]icosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

N-[(E,2S,3R)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhenicos-8-en-2-yl]heptadecanamide

N-[(E,2S,3R)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhenicos-8-en-2-yl]heptadecanamide

C44H85NO8 (755.627485)


   

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-[[(E)-icos-11-enoyl]amino]octadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2S,3R,4E,8E)-3-hydroxy-2-[[(E)-icos-11-enoyl]amino]octadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

(E)-N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadecan-2-yl]docos-13-enamide

(E)-N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadecan-2-yl]docos-13-enamide

C44H85NO8 (755.627485)


   

N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentadec-8-en-2-yl]tricosanamide

N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentadec-8-en-2-yl]tricosanamide

C44H85NO8 (755.627485)


   

N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicos-4-en-2-yl]octadecanamide

N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicos-4-en-2-yl]octadecanamide

C44H85NO8 (755.627485)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-icos-1-enoxy]propan-2-yl] (9E,11E)-octadeca-9,11-dienoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-icos-1-enoxy]propan-2-yl] (9E,11E)-octadeca-9,11-dienoate

C43H82NO7P (755.5828592)


   

2-[[(2S,3R,4E,8E)-2-[[(E)-heptadec-9-enoyl]amino]-3-hydroxyhenicosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2S,3R,4E,8E)-2-[[(E)-heptadec-9-enoyl]amino]-3-hydroxyhenicosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-icos-1-enoxy]propan-2-yl] (9E,12E)-octadeca-9,12-dienoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-icos-1-enoxy]propan-2-yl] (9E,12E)-octadeca-9,12-dienoate

C43H82NO7P (755.5828592)


   

(E)-N-[(2S,3R)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhenicosan-2-yl]heptadec-9-enamide

(E)-N-[(2S,3R)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhenicosan-2-yl]heptadec-9-enamide

C44H85NO8 (755.627485)


   

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(9E,12E)-octadeca-9,12-dienoyl]amino]icos-8-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(9E,12E)-octadeca-9,12-dienoyl]amino]icos-8-enoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[[(2S,3R,4E,8E)-2-[[(E)-hexadec-9-enoyl]amino]-3-hydroxydocosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2S,3R,4E,8E)-2-[[(E)-hexadec-9-enoyl]amino]-3-hydroxydocosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

(E)-N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadecan-2-yl]icos-11-enamide

(E)-N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadecan-2-yl]icos-11-enamide

C44H85NO8 (755.627485)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-icos-1-enoxy]propan-2-yl] (2E,4E)-octadeca-2,4-dienoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-icos-1-enoxy]propan-2-yl] (2E,4E)-octadeca-2,4-dienoate

C43H82NO7P (755.5828592)


   

(E)-N-[(2S,3R)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicosan-2-yl]octadec-9-enamide

(E)-N-[(2S,3R)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicosan-2-yl]octadec-9-enamide

C44H85NO8 (755.627485)


   

N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradec-8-en-2-yl]tetracosanamide

N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradec-8-en-2-yl]tetracosanamide

C44H85NO8 (755.627485)


   

2-[[(2S,3R,4E,8E)-2-[[(E)-docos-13-enoyl]amino]-3-hydroxyhexadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2S,3R,4E,8E)-2-[[(E)-docos-13-enoyl]amino]-3-hydroxyhexadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxynonadec-4-en-2-yl]nonadecanamide

N-[(E,2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxynonadec-4-en-2-yl]nonadecanamide

C44H85NO8 (755.627485)


   

(E)-N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradecan-2-yl]tetracos-15-enamide

(E)-N-[(2S,3R)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradecan-2-yl]tetracos-15-enamide

C44H85NO8 (755.627485)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(tetracosanoylamino)tetradeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(tetracosanoylamino)tetradeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[[(4E,8E,12E)-2-(hexadecanoylamino)-3-hydroxydocosa-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E,12E)-2-(hexadecanoylamino)-3-hydroxydocosa-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[[(4E,8E,12E)-2-(henicosanoylamino)-3-hydroxyheptadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E,12E)-2-(henicosanoylamino)-3-hydroxyheptadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-tridec-8-enoyl]amino]pentacosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-tridec-8-enoyl]amino]pentacosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]tetracosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]tetracosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[[(4E,8E)-2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxyhexacosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxyhexacosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-tetracos-11-enoyl]amino]tetradeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-tetracos-11-enoyl]amino]tetradeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[[(4E,8E,12E)-2-(heptadecanoylamino)-3-hydroxyhenicosa-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E,12E)-2-(heptadecanoylamino)-3-hydroxyhenicosa-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[[(4E,8E)-2-[[(Z)-docos-11-enoyl]amino]-3-hydroxyhexadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-[[(Z)-docos-11-enoyl]amino]-3-hydroxyhexadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(18Z,21Z)-tetracosa-18,21-dienoyl]amino]tetradec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(18Z,21Z)-tetracosa-18,21-dienoyl]amino]tetradec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(octadecanoylamino)icosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(octadecanoylamino)icosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[[(4E,8E)-2-[[(Z)-hexadec-7-enoyl]amino]-3-hydroxydocosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-[[(Z)-hexadec-7-enoyl]amino]-3-hydroxydocosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(nonadecanoylamino)nonadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(nonadecanoylamino)nonadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(pentadecanoylamino)tricosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(pentadecanoylamino)tricosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]tricosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]tricosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(tridecanoylamino)pentacosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(tridecanoylamino)pentacosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]octadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]octadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-octadec-11-enoyl]amino]icosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-octadec-11-enoyl]amino]icosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(tricosanoylamino)pentadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(tricosanoylamino)pentadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(tetradecanoylamino)tetracosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(tetradecanoylamino)tetracosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[[(E)-2-[[(4Z,7Z)-hexadeca-4,7-dienoyl]amino]-3-hydroxydocos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(4Z,7Z)-hexadeca-4,7-dienoyl]amino]-3-hydroxydocos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[[(E)-2-[[(14Z,16Z)-docosa-14,16-dienoyl]amino]-3-hydroxyhexadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(14Z,16Z)-docosa-14,16-dienoyl]amino]-3-hydroxyhexadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[[(4E,8E,12E)-2-(docosanoylamino)-3-hydroxyhexadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E,12E)-2-(docosanoylamino)-3-hydroxyhexadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-tricos-11-enoyl]amino]pentadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-tricos-11-enoyl]amino]pentadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[[(4E,8E,12E)-2-(dodecanoylamino)-3-hydroxyhexacosa-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E,12E)-2-(dodecanoylamino)-3-hydroxyhexacosa-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[[(4E,8E)-2-[[(Z)-henicos-9-enoyl]amino]-3-hydroxyheptadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-[[(Z)-henicos-9-enoyl]amino]-3-hydroxyheptadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(10Z,12Z)-octadeca-10,12-dienoyl]amino]icos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(10Z,12Z)-octadeca-10,12-dienoyl]amino]icos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]nonadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]nonadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(icosanoylamino)octadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(icosanoylamino)octadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[[(E)-2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxydocos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxydocos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(pentanoylamino)tritriaconta-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(pentanoylamino)tritriaconta-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]nonadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]nonadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[[(4E,8E,12E)-2-(heptanoylamino)-3-hydroxyhentriaconta-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E,12E)-2-(heptanoylamino)-3-hydroxyhentriaconta-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[3-hydroxy-2-[[(16Z,19Z,22Z)-triaconta-16,19,22-trienoyl]amino]octoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-hydroxy-2-[[(16Z,19Z,22Z)-triaconta-16,19,22-trienoyl]amino]octoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[[(4E,8E)-2-[[(Z)-hexacos-15-enoyl]amino]-3-hydroxydodeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-[[(Z)-hexacos-15-enoyl]amino]-3-hydroxydodeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]pentacosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]pentacosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(17Z,20Z)-octacosa-17,20-dienoyl]amino]dec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(17Z,20Z)-octacosa-17,20-dienoyl]amino]dec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[3-hydroxy-2-[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-hydroxy-2-[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(nonanoylamino)nonacosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(nonanoylamino)nonacosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[3-hydroxy-2-[[(14Z,17Z,20Z)-octacosa-14,17,20-trienoyl]amino]decoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-hydroxy-2-[[(14Z,17Z,20Z)-octacosa-14,17,20-trienoyl]amino]decoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(octanoylamino)triaconta-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(octanoylamino)triaconta-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[[(4E,8E,12E)-2-acetamido-3-hydroxyhexatriaconta-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E,12E)-2-acetamido-3-hydroxyhexatriaconta-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]icos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]icos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[[(E)-2-[[(15Z,18Z)-hexacosa-15,18-dienoyl]amino]-3-hydroxydodec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(15Z,18Z)-hexacosa-15,18-dienoyl]amino]-3-hydroxydodec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(19Z,22Z)-triaconta-19,22-dienoyl]amino]oct-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(19Z,22Z)-triaconta-19,22-dienoyl]amino]oct-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[[(E)-2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxyheptadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxyheptadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]icosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]icosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(propanoylamino)pentatriaconta-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(propanoylamino)pentatriaconta-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[[(4E,8E,12E)-2-(hexanoylamino)-3-hydroxydotriaconta-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E,12E)-2-(hexanoylamino)-3-hydroxydotriaconta-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[[(4E,8E)-2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxyhenicosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxyhenicosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[[(4E,8E)-2-[[(Z)-henicos-11-enoyl]amino]-3-hydroxyheptadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-[[(Z)-henicos-11-enoyl]amino]-3-hydroxyheptadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[[(4E,8E,12E)-2-(butanoylamino)-3-hydroxytetratriaconta-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E,12E)-2-(butanoylamino)-3-hydroxytetratriaconta-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[[(4E,8E,12E)-2-(decanoylamino)-3-hydroxyoctacosa-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E,12E)-2-(decanoylamino)-3-hydroxyoctacosa-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-tetracos-13-enoyl]amino]tetradeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(Z)-tetracos-13-enoyl]amino]tetradeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[[2-[[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]amino]-3-hydroxyhexadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]amino]-3-hydroxyhexadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[3-hydroxy-2-[[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]amino]icosoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-hydroxy-2-[[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]amino]icosoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(undecanoylamino)heptacosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(undecanoylamino)heptacosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[[2-[[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]amino]-3-hydroxydodecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]amino]-3-hydroxydodecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[[(E)-2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3-hydroxyhexadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3-hydroxyhexadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]tetradecoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]tetradecoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[[(4E,8E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxydocosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxydocosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[[2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxydocosoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxydocosoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[[(4E,8E)-2-[[(Z)-docos-13-enoyl]amino]-3-hydroxyhexadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-[[(Z)-docos-13-enoyl]amino]-3-hydroxyhexadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[[(E)-2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxyhenicos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxyhenicos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(13Z,16Z)-tetracosa-13,16-dienoyl]amino]tetradec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(13Z,16Z)-tetracosa-13,16-dienoyl]amino]tetradec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O6P+ (755.6066674000001)


   

beta-D-glucosyl-N-eicosanoylsphingosine

beta-D-glucosyl-N-eicosanoylsphingosine

C44H85NO8 (755.627485)


A beta-D-glucosyl-N-acylsphingosine in which the acyl group is specified as eicosanoyl.

   

Galactosylceramide (d18:1/20:0)

Galactosylceramide (d18:1/20:0)

C44H85NO8 (755.627485)


   

N-(2-hydroxy-octadecanoyl)-1-beta-glucosyl-9-methyl-sphinga-4E,8E-dienine

N-(2-hydroxy-octadecanoyl)-1-beta-glucosyl-9-methyl-sphinga-4E,8E-dienine

C43H81NO9 (755.5911016)


   

beta-D-galactosyl-(1<->1)-N-(docosanoyl)hexadecasphingosine

beta-D-galactosyl-(1<->1)-N-(docosanoyl)hexadecasphingosine

C44H85NO8 (755.627485)


A galactosylceramide obtained by formal condensation of the carboxy group of docosanoic acid with the amino group of beta-D-galactosyl-(1<->1)-hexadecasphingosine.

   

beta-D-glucosyl-(1<->1)-N-(docosanoyl)hexadecasphingosine

beta-D-glucosyl-(1<->1)-N-(docosanoyl)hexadecasphingosine

C44H85NO8 (755.627485)


A beta-D-glucosyl-(1<->1)-N-acylhexadecasphingosine in which the ceramide N-acyl group is specified as docosanoyl.

   

N-hexacosanoylsphingosine 1-phosphate(2-)

N-hexacosanoylsphingosine 1-phosphate(2-)

C44H86NO6P (755.6192426)


A ceramide 1-phosphate(2-) in which the N-acyl group is specified as hexacosanoyl.

   

Hex1Cer(38:1)

Hex1Cer(d18:1_20:0)

C44H85NO8 (755.627485)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

MePC(34:3)

MePC(16:1(1)_18:2)

C43H82NO7P (755.5828592)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

Hex1Cer(37:2)

Hex1Cer(t17:0_20:2)

C43H81NO9 (755.5911016)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

dMePE(36:3)

dMePE(18:1(1)_18:2)

C43H82NO7P (755.5828592)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   
   
   
   
   
   
   

PC P-17:0/18:2 or PC O-17:1/18:2

PC P-17:0/18:2 or PC O-17:1/18:2

C43H82NO7P (755.5828592)


   
   

PC P-18:0/17:2 or PC O-18:1/17:2

PC P-18:0/17:2 or PC O-18:1/17:2

C43H82NO7P (755.5828592)


   
   

PC P-18:1/17:1 or PC O-18:2/17:1

PC P-18:1/17:1 or PC O-18:2/17:1

C43H82NO7P (755.5828592)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

GalCer 14:0;O2/24:1

GalCer 14:0;O2/24:1

C44H85NO8 (755.627485)


   

GalCer 14:1;O2/24:0

GalCer 14:1;O2/24:0

C44H85NO8 (755.627485)


   

GalCer 14:2;O2/23:0;O

GalCer 14:2;O2/23:0;O

C43H81NO9 (755.5911016)


   

GalCer 15:0;O3/22:2

GalCer 15:0;O3/22:2

C43H81NO9 (755.5911016)


   

GalCer 15:1;O2/22:1;O

GalCer 15:1;O2/22:1;O

C43H81NO9 (755.5911016)


   

GalCer 15:1;O2/23:0

GalCer 15:1;O2/23:0

C44H85NO8 (755.627485)


   

GalCer 15:2;O2/22:0;O

GalCer 15:2;O2/22:0;O

C43H81NO9 (755.5911016)


   

GalCer 16:0;O2/22:1

GalCer 16:0;O2/22:1

C44H85NO8 (755.627485)


   

GalCer 16:1;O2/22:0

GalCer 16:1;O2/22:0

C44H85NO8 (755.627485)


   

GalCer 16:2;O2/21:0;O

GalCer 16:2;O2/21:0;O

C43H81NO9 (755.5911016)


   

GalCer 17:0;O3/20:2

GalCer 17:0;O3/20:2

C43H81NO9 (755.5911016)


   

GalCer 17:1;O2/20:1;O

GalCer 17:1;O2/20:1;O

C43H81NO9 (755.5911016)


   

GalCer 17:1;O2/21:0

GalCer 17:1;O2/21:0

C44H85NO8 (755.627485)


   

GalCer 17:2;O2/20:0;O

GalCer 17:2;O2/20:0;O

C43H81NO9 (755.5911016)


   

GalCer 18:0;O2/20:1

GalCer 18:0;O2/20:1

C44H85NO8 (755.627485)


   

GalCer 18:1;O2/20:0

GalCer 18:1;O2/20:0

C44H85NO8 (755.627485)


   

GalCer 18:2;O2/19:0;O

GalCer 18:2;O2/19:0;O

C43H81NO9 (755.5911016)


   

GalCer 19:0;O3/18:2

GalCer 19:0;O3/18:2

C43H81NO9 (755.5911016)


   

GalCer 19:1;O2/18:1;O

GalCer 19:1;O2/18:1;O

C43H81NO9 (755.5911016)


   

GalCer 19:1;O2/19:0

GalCer 19:1;O2/19:0

C44H85NO8 (755.627485)


   

GalCer 19:2;O2/18:0;O

GalCer 19:2;O2/18:0;O

C43H81NO9 (755.5911016)


   

GalCer 20:0;O2/18:1

GalCer 20:0;O2/18:1

C44H85NO8 (755.627485)


   

GalCer 20:0;O3/17:2

GalCer 20:0;O3/17:2

C43H81NO9 (755.5911016)


   

GalCer 20:1;O2/18:0

GalCer 20:1;O2/18:0

C44H85NO8 (755.627485)


   

GalCer 20:2;O2/17:0;O

GalCer 20:2;O2/17:0;O

C43H81NO9 (755.5911016)


   

GalCer 21:0;O2/17:1

GalCer 21:0;O2/17:1

C44H85NO8 (755.627485)


   

GalCer 21:1;O2/17:0

GalCer 21:1;O2/17:0

C44H85NO8 (755.627485)


   

GalCer 21:2;O2/16:0;O

GalCer 21:2;O2/16:0;O

C43H81NO9 (755.5911016)


   

GalCer 22:0;O2/16:1

GalCer 22:0;O2/16:1

C44H85NO8 (755.627485)


   

GalCer 22:1;O2/16:0

GalCer 22:1;O2/16:0

C44H85NO8 (755.627485)


   

GalCer 22:2;O2/15:0;O

GalCer 22:2;O2/15:0;O

C43H81NO9 (755.5911016)


   
   
   
   

GlcCer 14:0;O2/24:1

GlcCer 14:0;O2/24:1

C44H85NO8 (755.627485)


   

GlcCer 14:1;O2/24:0

GlcCer 14:1;O2/24:0

C44H85NO8 (755.627485)


   

GlcCer 14:2;O2/23:0;O

GlcCer 14:2;O2/23:0;O

C43H81NO9 (755.5911016)


   

GlcCer 15:0;O3/22:2

GlcCer 15:0;O3/22:2

C43H81NO9 (755.5911016)


   

GlcCer 15:1;O2/22:1;O

GlcCer 15:1;O2/22:1;O

C43H81NO9 (755.5911016)


   

GlcCer 15:1;O2/23:0

GlcCer 15:1;O2/23:0

C44H85NO8 (755.627485)


   

GlcCer 15:2;O2/22:0;O

GlcCer 15:2;O2/22:0;O

C43H81NO9 (755.5911016)


   

GlcCer 15:2;O2(4E,6E)/22:0;O

GlcCer 15:2;O2(4E,6E)/22:0;O

C43H81NO9 (755.5911016)


   

GlcCer 16:0;O2/22:1

GlcCer 16:0;O2/22:1

C44H85NO8 (755.627485)


   

GlcCer 16:1;O2/22:0

GlcCer 16:1;O2/22:0

C44H85NO8 (755.627485)


   

GlcCer 16:2;O2/21:0;O

GlcCer 16:2;O2/21:0;O

C43H81NO9 (755.5911016)


   

GlcCer 17:0;O3/20:2

GlcCer 17:0;O3/20:2

C43H81NO9 (755.5911016)


   

GlcCer 17:1;O2/20:1;O

GlcCer 17:1;O2/20:1;O

C43H81NO9 (755.5911016)


   

GlcCer 17:1;O2/21:0

GlcCer 17:1;O2/21:0

C44H85NO8 (755.627485)


   

GlcCer 17:2;O2/20:0;O

GlcCer 17:2;O2/20:0;O

C43H81NO9 (755.5911016)


   

GlcCer 18:0;O2/20:1

GlcCer 18:0;O2/20:1

C44H85NO8 (755.627485)


   

GlcCer 18:1;O2/20:0

GlcCer 18:1;O2/20:0

C44H85NO8 (755.627485)


   

GlcCer 18:2;O2/19:0;O

GlcCer 18:2;O2/19:0;O

C43H81NO9 (755.5911016)


   

GlcCer 19:0;O3/18:2

GlcCer 19:0;O3/18:2

C43H81NO9 (755.5911016)


   

GlcCer 19:1;O2/18:1;O

GlcCer 19:1;O2/18:1;O

C43H81NO9 (755.5911016)


   

GlcCer 19:1;O2/19:0

GlcCer 19:1;O2/19:0

C44H85NO8 (755.627485)


   

GlcCer 19:2;O2/18:0;O

GlcCer 19:2;O2/18:0;O

C43H81NO9 (755.5911016)


   

GlcCer 20:0;O2/18:1

GlcCer 20:0;O2/18:1

C44H85NO8 (755.627485)


   

GlcCer 20:0;O3/17:2

GlcCer 20:0;O3/17:2

C43H81NO9 (755.5911016)


   

GlcCer 20:1;O2/18:0

GlcCer 20:1;O2/18:0

C44H85NO8 (755.627485)


   

GlcCer 20:2;O2/17:0;O

GlcCer 20:2;O2/17:0;O

C43H81NO9 (755.5911016)


   

GlcCer 21:0;O2/17:1

GlcCer 21:0;O2/17:1

C44H85NO8 (755.627485)


   

GlcCer 21:1;O2/17:0

GlcCer 21:1;O2/17:0

C44H85NO8 (755.627485)


   

GlcCer 21:2;O2/16:0;O

GlcCer 21:2;O2/16:0;O

C43H81NO9 (755.5911016)


   

GlcCer 22:0;O2/16:1

GlcCer 22:0;O2/16:1

C44H85NO8 (755.627485)


   

GlcCer 22:1;O2/16:0

GlcCer 22:1;O2/16:0

C44H85NO8 (755.627485)


   

GlcCer 22:2;O2/15:0;O

GlcCer 22:2;O2/15:0;O

C43H81NO9 (755.5911016)


   
   
   
   

HexCer 14:0;O2/24:1

HexCer 14:0;O2/24:1

C44H85NO8 (755.627485)


   

HexCer 14:2;O2/23:0;2OH

HexCer 14:2;O2/23:0;2OH

C43H81NO9 (755.5911016)


   

HexCer 14:2;O2/23:0;3OH

HexCer 14:2;O2/23:0;3OH

C43H81NO9 (755.5911016)


   

HexCer 14:2;O2/23:0;O

HexCer 14:2;O2/23:0;O

C43H81NO9 (755.5911016)


   

HexCer 15:0;O3/22:2

HexCer 15:0;O3/22:2

C43H81NO9 (755.5911016)


   

HexCer 15:1;O2/22:1;2OH

HexCer 15:1;O2/22:1;2OH

C43H81NO9 (755.5911016)


   

HexCer 15:1;O2/22:1;3OH

HexCer 15:1;O2/22:1;3OH

C43H81NO9 (755.5911016)


   

HexCer 15:1;O2/22:1;O

HexCer 15:1;O2/22:1;O

C43H81NO9 (755.5911016)


   

HexCer 15:1;O2/23:0

HexCer 15:1;O2/23:0

C44H85NO8 (755.627485)


   

HexCer 15:2;O2/22:0;2OH

HexCer 15:2;O2/22:0;2OH

C43H81NO9 (755.5911016)


   

HexCer 15:2;O2/22:0;3OH

HexCer 15:2;O2/22:0;3OH

C43H81NO9 (755.5911016)


   

HexCer 15:2;O2/22:0;O

HexCer 15:2;O2/22:0;O

C43H81NO9 (755.5911016)


   

HexCer 16:0;O2/22:1

HexCer 16:0;O2/22:1

C44H85NO8 (755.627485)


   

HexCer 16:1;O2/22:0

HexCer 16:1;O2/22:0

C44H85NO8 (755.627485)


   

HexCer 16:2;O2/21:0;2OH

HexCer 16:2;O2/21:0;2OH

C43H81NO9 (755.5911016)


   

HexCer 16:2;O2/21:0;3OH

HexCer 16:2;O2/21:0;3OH

C43H81NO9 (755.5911016)


   

HexCer 16:2;O2/21:0;O

HexCer 16:2;O2/21:0;O

C43H81NO9 (755.5911016)


   

HexCer 17:0;O3/20:2

HexCer 17:0;O3/20:2

C43H81NO9 (755.5911016)


   

HexCer 17:1;O2/20:1;2OH

HexCer 17:1;O2/20:1;2OH

C43H81NO9 (755.5911016)


   

HexCer 17:1;O2/20:1;3OH

HexCer 17:1;O2/20:1;3OH

C43H81NO9 (755.5911016)


   

HexCer 17:1;O2/20:1;O

HexCer 17:1;O2/20:1;O

C43H81NO9 (755.5911016)


   

HexCer 17:1;O2/21:0

HexCer 17:1;O2/21:0

C44H85NO8 (755.627485)


   

HexCer 17:2;O2/20:0;2OH

HexCer 17:2;O2/20:0;2OH

C43H81NO9 (755.5911016)


   

HexCer 17:2;O2/20:0;3OH

HexCer 17:2;O2/20:0;3OH

C43H81NO9 (755.5911016)


   

HexCer 17:2;O2/20:0;O

HexCer 17:2;O2/20:0;O

C43H81NO9 (755.5911016)


   

HexCer 18:0;O2/20:1

HexCer 18:0;O2/20:1

C44H85NO8 (755.627485)


   

HexCer 18:1;O2/20:0

HexCer 18:1;O2/20:0

C44H85NO8 (755.627485)


   

HexCer 18:2;O2/19:0;2OH

HexCer 18:2;O2/19:0;2OH

C43H81NO9 (755.5911016)


   

HexCer 18:2;O2/19:0;3OH

HexCer 18:2;O2/19:0;3OH

C43H81NO9 (755.5911016)


   

HexCer 18:2;O2/19:0;O

HexCer 18:2;O2/19:0;O

C43H81NO9 (755.5911016)


   

HexCer 19:0;O3/18:2

HexCer 19:0;O3/18:2

C43H81NO9 (755.5911016)


   

HexCer 19:1;O2/18:1;2OH

HexCer 19:1;O2/18:1;2OH

C43H81NO9 (755.5911016)


   

HexCer 19:1;O2/18:1;3OH

HexCer 19:1;O2/18:1;3OH

C43H81NO9 (755.5911016)


   

HexCer 19:1;O2/18:1;O

HexCer 19:1;O2/18:1;O

C43H81NO9 (755.5911016)


   

HexCer 19:1;O2/19:0

HexCer 19:1;O2/19:0

C44H85NO8 (755.627485)


   

HexCer 19:2;O2/18:0;2OH

HexCer 19:2;O2/18:0;2OH

C43H81NO9 (755.5911016)


   

HexCer 19:2;O2/18:0;3OH

HexCer 19:2;O2/18:0;3OH

C43H81NO9 (755.5911016)


   

HexCer 19:2;O2/18:0;O

HexCer 19:2;O2/18:0;O

C43H81NO9 (755.5911016)


   

HexCer 20:0;O2/18:1

HexCer 20:0;O2/18:1

C44H85NO8 (755.627485)


   

HexCer 20:0;O3/17:2

HexCer 20:0;O3/17:2

C43H81NO9 (755.5911016)


   

HexCer 20:1;O2/18:0

HexCer 20:1;O2/18:0

C44H85NO8 (755.627485)


   

HexCer 20:2;O2/17:0;2OH

HexCer 20:2;O2/17:0;2OH

C43H81NO9 (755.5911016)


   

HexCer 20:2;O2/17:0;3OH

HexCer 20:2;O2/17:0;3OH

C43H81NO9 (755.5911016)


   

HexCer 20:2;O2/17:0;O

HexCer 20:2;O2/17:0;O

C43H81NO9 (755.5911016)


   

HexCer 21:0;O2/17:1

HexCer 21:0;O2/17:1

C44H85NO8 (755.627485)


   

HexCer 21:1;O2/17:0

HexCer 21:1;O2/17:0

C44H85NO8 (755.627485)


   

HexCer 21:2;O2/16:0;2OH

HexCer 21:2;O2/16:0;2OH

C43H81NO9 (755.5911016)


   

HexCer 21:2;O2/16:0;3OH

HexCer 21:2;O2/16:0;3OH

C43H81NO9 (755.5911016)


   

HexCer 21:2;O2/16:0;O

HexCer 21:2;O2/16:0;O

C43H81NO9 (755.5911016)


   

HexCer 22:0;O2/16:1

HexCer 22:0;O2/16:1

C44H85NO8 (755.627485)


   

HexCer 22:1;O2/16:0

HexCer 22:1;O2/16:0

C44H85NO8 (755.627485)


   

HexCer 22:2;O2/15:0;2OH

HexCer 22:2;O2/15:0;2OH

C43H81NO9 (755.5911016)


   

HexCer 22:2;O2/15:0;3OH

HexCer 22:2;O2/15:0;3OH

C43H81NO9 (755.5911016)


   

HexCer 22:2;O2/15:0;O

HexCer 22:2;O2/15:0;O

C43H81NO9 (755.5911016)


   
   
   

2-hydroxy-n-(3-hydroxy-9,17-dimethyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadeca-4,8-dien-2-yl)-15-methylhexadecanimidic acid

2-hydroxy-n-(3-hydroxy-9,17-dimethyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadeca-4,8-dien-2-yl)-15-methylhexadecanimidic acid

C43H81NO9 (755.5911016)


   

2-hydroxy-n-(3-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}docosa-4,13-dien-2-yl)pentadecanimidic acid

2-hydroxy-n-(3-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}docosa-4,13-dien-2-yl)pentadecanimidic acid

C43H81NO9 (755.5911016)